Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Emmeline L Cheng"'
Publikováno v:
ACS Applied Materials & Interfaces. 14:44136-44146
In both biomedical research and clinical cell therapy manufacturing, there is a need for cell isolation systems that recover purified cells in the absence of any selection agent. Reported traceless cell isolation methods using engineered antigen-bind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f71f6d3b7934f3ce0970b815466dccf
https://doi.org/10.1021/acsami.2c11783
https://doi.org/10.1021/acsami.2c11783
Autor:
Frank DiMaio, Ha V. Dang, Suzie H. Pun, David Veesler, Stephen J. Salipante, Davide Corti, Lucy F. Yang, Drew L. Sellers, Alexandra C. Walls, Nataly Kacherovsky, Matthew McCallum, Ian I. Cardle, Emmeline L Cheng
Publikováno v:
Angewandte Chemie (International Ed. in English)
The coronavirus disease 2019 (COVID‐19) pandemic has devastated families and disrupted healthcare, economies and societies across the globe. Molecular recognition agents that are specific for distinct viral proteins are critical components for rapi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67c878949205303a03bbfbfbf2f91171
http://europepmc.org/articles/PMC8426805
http://europepmc.org/articles/PMC8426805
Autor:
Ian I. Cardle, Jonathan L. Yu, Nataly Kacherovsky, Suzie H. Pun, Michael L. Baldwin, Stephen J. Salipante, Michael C. Jensen, Emmeline L Cheng
Publikováno v:
Nature Biomedical Engineering. 3:783-795
Chimeric antigen receptor T-cell therapies using defined product compositions require high-purity T-cell isolation systems that, unlike immunomagnetic positive enrichment, are inexpensive and leave no trace on the final cell product. Here, we show th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0244533c7b12f81b74410822e8507204
https://doi.org/10.1038/s41551-019-0411-6
https://doi.org/10.1038/s41551-019-0411-6
Publikováno v:
Biomaterials Science. 7:789-797
T cells have emerged as a therapeutically-relevant target for ex vivo gene delivery and editing. However, most commercially available reagents cannot transfect T cells and designing cationic polymers for non-viral gene delivery to T cells has resulte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a50acfa12b29ec5154af7dd4ac55d53e
https://doi.org/10.1039/c8bm01262h
https://doi.org/10.1039/c8bm01262h
Autor:
Nataly, Kacherovsky, Ian I, Cardle, Emmeline L, Cheng, Jonathan L, Yu, Michael L, Baldwin, Stephen J, Salipante, Michael C, Jensen, Suzie H, Pun
Publikováno v:
Nature biomedical engineering
Chimeric antigen receptor (CAR) T-cell therapies using defined product compositions require high-purity T-cell isolation systems that, unlike immunomagnetic positive enrichment, are inexpensive and leave no trace on the final cell product. Here, we s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b3dbaa6a536974ba8e3fb176c7b30d22
https://pubmed.ncbi.nlm.nih.gov/31209354
https://pubmed.ncbi.nlm.nih.gov/31209354